Restless legs syndrome future or investigational therapies: Difference between revisions
Created page with "__NOTOC__ {{Restless legs syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{re..." |
m Bot: Removing from Primary care |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Restless legs syndrome}} | {{Restless legs syndrome}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[help:How to Edit a Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[help:How to Edit a Page|here]] to learn about editing. | ||
{{CMG}} | |||
==Future or Investigational Therapies== | |||
===Controversies=== | |||
Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation <ref>* [http://www.rls.org/NETCOMMUNITY/Page.aspx?&pid=471&srcid=-2 RLS Foundation]</ref> received 44% of its $1.4 million in funding from these pharmaceutical groups<ref>[http://www.newscientist.com/channel/health/mg19225755.100-patient-groups-special-swallowing-the-best-advice.html Marshall, Jessica, and Peter Aldhous. "Patient Groups Special." New Scientist, 10/26/06]</ref>. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Sleep disorders]] | [[Category:Sleep disorders]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Latest revision as of 23:58, 29 July 2020
|
Restless legs syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Restless legs syndrome future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Restless legs syndrome future or investigational therapies |
|
FDA on Restless legs syndrome future or investigational therapies |
|
CDC on Restless legs syndrome future or investigational therapies |
|
Restless legs syndrome future or investigational therapies in the news |
|
Blogs on Restless legs syndrome future or investigational therapies |
|
Risk calculators and risk factors for Restless legs syndrome future or investigational therapies |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or Investigational Therapies
Controversies
Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation [1] received 44% of its $1.4 million in funding from these pharmaceutical groups[2]. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients.